Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1994-04-14
1997-06-10
Bawa, Raj
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424451, 424459, 424458, 424457, 424464, 424469, 424468, 424471, 424490, A61K 954
Patent
active
056373201
ABSTRACT:
A once-daily naproxen formulation for oral administration having a first portion of the naproxen as a multi-particulate pellet form, each pellet having a core of naproxen or a pharmaceutically acceptable salt thereof in association with an organic acid, the core being surrounded by a multi-layer membrane and optionally a second portion of naproxen formulated to release the drug promptly following oral administration.
REFERENCES:
patent: 4783337 (1988-11-01), Wong et al.
patent: 4803079 (1989-02-01), Hsiao et al.
patent: 4867984 (1989-09-01), Patel
patent: 5024842 (1991-06-01), Edgren
J.G. Kelly, C.D. Kinney, J.G. Devane, S. Mulligan & B.V. Colgan--"Pharmacokinetic properties and clinical efficacy of once-daily sustained-release naproxen", Eur. J. Clin. Pharmacol (1989) 36:383-388.
Bourke Edward A.
Mulligan Seamus
Bawa Raj
Church Marla J.
Elan Corporation, plc
LandOfFree
Controlled absorption naproxen formulation for once-daily admini does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled absorption naproxen formulation for once-daily admini, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled absorption naproxen formulation for once-daily admini will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-763038